Literature DB >> 22334618

The matri-cellular proteins 'cysteine-rich, angiogenic-inducer, 61' and 'connective tissue growth factor' are regulated in experimentally-induced sepsis with multiple organ dysfunction.

Claus V B Hviid1, Johanna Samulin Erdem, David Kunke, Shakil M Ahmed, Signe F Kjeldsen, Yun Yong Wang, Håvard Attramadal, Ansgar O Aasen.   

Abstract

Organ failure is a severe complication in sepsis for which the pathophysiology remains incompletely understood. Recently, the matri-cellular cysteine-rich, angiogenic induced, 61 (Cyr61/CCN1); connective tissue growth factor (Ctgf/CCN2); and nephroblastoma overexpressed gene (Nov/CCN3) (CCN)-protein family have been attributed organ-protective properties. Their expression is sensitive to mediators of sepsis pathophysiology but a potential role in sepsis remains elusive. To provide an initial assessment, 50 rats were subjected to 18 h of cecal-ligation and puncture or sham operation. Hepatic and pulmonary CCN1 mRNA displayed an average 7.4- and 3.3-fold induction, while its cardiac expression was unchanged. The changes coincided with excessive hepatic and pulmonary inflammatory gene activation and a restricted cardiac inflammation. Furthermore, hepatocytes displayed a dosage-dependent CCN1 mRNA response in vitro, supporting a cytokine-mediated CCN1 regulation in sepsis. CCN2 mRNA was 2.2-fold induced in the liver, while 2.0-fold and 1.4-fold repressed in the heart and lung. Meanwhile, it did not respond to TNF-α exposure in vitro, which indicates different means of regulation than for CCN1. Taken together, this study provides the first evidence for multi-organ regulation of CCN1 and CCN2 in early stages of sepsis, and implies the eruption of inflammatory mediators as a potential mechanism behind the observed CCN1 regulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334618     DOI: 10.1177/1753425912436764

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  8 in total

1.  Regulation of pancreatic inflammation by connective tissue growth factor (CTGF/CCN2).

Authors:  Alyssa Charrier; Ruju Chen; Sherri Kemper; David R Brigstock
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

2.  CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation.

Authors:  Beat A Imhof; Stephane Jemelin; Romain Ballet; Christian Vesin; Marc Schapira; Melis Karaca; Yalin Emre
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

Review 3.  Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?

Authors:  Brahim Chaqour
Journal:  J Cell Commun Signal       Date:  2019-08-02       Impact factor: 5.782

4.  Microarray meta-analysis identifies acute lung injury biomarkers in donor lungs that predict development of primary graft failure in recipients.

Authors:  Pingzhao Hu; Xinchen Wang; Jack J Haitsma; Suleiman Furmli; Hussain Masoom; Mingyao Liu; Yumiko Imai; Arthur S Slutsky; Joseph Beyene; Celia M T Greenwood; Claudia dos Santos
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

5.  The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing.

Authors:  Joon-Il Jun; Ki-Hyun Kim; Lester F Lau
Journal:  Nat Commun       Date:  2015-06-16       Impact factor: 14.919

6.  Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer.

Authors:  Xinpeng Li; Naxin Yuan; Lingdan Lin; Lixia Yin; Yiqing Qu
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

7.  Association of serum Cyr61 levels with peripheral arterial disease in subjects with type 2 diabetes.

Authors:  Bin Feng; Guidong Xu; Kangyun Sun; Kaipeng Duan; Bimin Shi; Nannan Zhang
Journal:  Cardiovasc Diabetol       Date:  2020-11-22       Impact factor: 9.951

Review 8.  The Roles of CCN1/CYR61 in Pulmonary Diseases.

Authors:  Yin Zhu; Sultan Almuntashiri; Yohan Han; Xiaoyun Wang; Payaningal R Somanath; Duo Zhang
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.